Verified· 2 sources

Axanton Technology GmbH

Summary

About the company

Axanton Technology GmbH develops MEMS (Molecules Establishing Membrane Signaling), a technology for producing therapeutic biomolecules that target chemically modified membrane protein sequences to restore membrane protein homeostasis. The company conducts research and preclinical development of candidates such as A‑144 and holds patented technology for MEMS production.

AI-generated

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

Axanton Technology GmbH

About the company